Nuvectis Pharma, Inc. (NVCT) Q2 2024 Earnings
NVCT·Reported August 6, 2024·Before market open
Diluted EPS came in at $-0.26.
Diluted EPS
$-0.26met estimate
Consensus: $-0.26
Financial Snapshot
Trailing eight quarters through Q2 2024
Q2 2024 Earnings FAQ
Common questions about Nuvectis Pharma, Inc.'s Q2 2024 earnings report.
Nuvectis Pharma, Inc. (NVCT) reported Q2 2024 earnings on August 6, 2024 before market open.
Nuvectis Pharma, Inc. reported diluted EPS of $-0.26 for Q2 2024.
EPS beat the consensus estimate of $-0.26 by $0.00.
You can read the 10-Q periodic report (0001558370-24-010971) directly on SEC EDGAR. The filing index links above go to sec.gov.